HOME >> BIOLOGY >> NEWS
USC researchers determine mechanism of action of chemotherapy drug

LOS ANGELES, May 1 - The chemotherapy drug motexafin gadolinium (brand name: Xcytrin, manufactured by Pharmacyclics, Inc.) works to thwart cancer cells by disrupting key enzymes involved in cellular metabolism, according to a team of researchers led by Joseph Hacia, Ph.D., assistant professor of biochemistry and molecular biology at the Keck School of Medicine of the University of Southern California.

The cellular disruption results in increases in the amount of zinc available inside the cancer cells, and because zinc is involved in protein structure and function, leads to inhibition of enzyme activity and to the death of the cells.

A paper describing these findings was published in the May 1, 2005, issue of the journal Cancer Research.

In order to gain a better understanding of the mechanism of action of this novel chemotherapeutic agent, the researchers looked at gene expression profiles and other biochemical properties of cells from human lung, prostate and lymphoma cancer cell cultures that had been treated with motexafin gadolinium, or MGd. What they found was that the drug created oxidative stress in the tumor cells, increasing the levels of expression of the genes that produce metallothioneins.

The researchers showed that the increased metallothionein expression levels resulted from significantly increased levels of free-i.e., not protein-bound-zinc in the cells. The zinc, in turn, acted to inhibit an enzyme-thioredoxin reductase-that is an important component in the cell's antioxidant system, as well as important in DNA synthesis. In other words, thioredoxin reductase is key to the replication and survival of cells, and its inhibition ultimately leads to cell death.

"Our studies showed that MGd induces oxidative stress in cancer cells," says Hacia, who is a member of USC's Institute for Genetic Medicine, "and this leads to disruption of zinc metabolism and alteration of key enzymes and metabolites necessary for normal
'"/>

Contact: Sarah Huoh
shuoh@usc.edu
323-442-2830
University of Southern California
1-May-2005


Page: 1 2

Related biology news :

1. Innovative tagging technique may help researchers better protect fish stocks
2. Penn researchers discover how key protein stops inflammation
3. ASU researchers partner with UOP to make biofuel for military jets a reality
4. Einstein researchers prototype vaccine could provide improved protection against tuberculosis
5. Penn researchers discover pathway that eliminates genetic defects in red blood cells
6. U-M researchers find family of on switches that cause prostate cancer
7. 2007 EURYI: 20 young researchers to receive Nobel Prize-sized awards for breakthrough ideas
8. Pets could be source of multiresistant bacteria infections in humans, MU researchers investigate
9. MGH researchers confirm that bone marrow restores fertility in female mice
10. Smithsonians National Zoo researchers use electronic eggs to help save threatened species
11. U-M researchers identify gene involved in breast cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/27/2018)... ... November 27, 2018 , ... Victrex has ... solution with a broader range of usage temperature compared to existing polymers such ... its new VICTREX CT™ 200 for dynamic sealing applications where gases such as ...
(Date:11/27/2018)... ... 2018 , ... Veni Vici, or Anthony, is a competitive Hunter-Jumper owned by Lisa Companioni Smith. ... time, he was fourteen years old and Lisa was told he would never jump again ... trail horse. Devasted, Lisa sought the expert opinion of veterinarian and surgeon, Dr. Ruth-Anne ...
(Date:11/20/2018)... ... ... Cloudponics , maker of the GroBox , the intelligent, fully-automated ... for its industry-leading product during the holiday season. , Customers can save up ... payment options available on the Cloudponics website . , “We aim, through ...
Breaking Biology News(10 mins):
(Date:11/11/2018)... ... 2018 , ... Triple W, an innovator of connected health devices, today announced ... DFree ®, the first health tech wearable device for incontinence that monitors how ... bathroom. The announcement was made during CES Unveiled New York, an invite-only tech event ...
(Date:11/7/2018)... ... November 07, 2018 , ... Since September of this ... awareness of the adult tissue stem cell counting problem in stem cell medicine ... is intensifying this effort with new educational publications and presentations at clinical trial ...
(Date:11/5/2018)... Tenn. (PRWEB) , ... November 05, 2018 , ... ... radiology and telemedicine company backed by Siemens Healthineers and several healthcare VC firms ... based radiology solution and making a history by purchasing tokens and obtaining its ...
(Date:11/3/2018)... ... 01, 2018 , ... Triangle Insights Group, a premier life sciences consulting firm, ... private companies in the United States, appearing on this year’s Inc. 5000 list. ... percentage revenue growth over the previous three years. , Separately, Triangle Insights was ...
Breaking Biology Technology:
Cached News: